The Sharda-BASF dispute ended at the U.S. International Trade Commission (ITC) with consent orders, not a federal-court judgment after a trial. BASF had alleged that Sharda Cropchem Ltd. and Sharda USA LLC infringed a patent related to pyraclostrobin; the ITC investigation concerned products containing crystalline modification IV of the fungicide ingredient. Sharda sought termination under a consent-order stipulation, BASF did not oppose, and the Commission issued the orders in April 2022.
What the ITC decided—and what it did not
The ITC’s investigation, No. 337-TA-1303, concerned imported “products containing crystalline modification IV of pyraclostrobin and components thereof.” The notice identified claims 1–17 of U.S. Patent No. 7,816,392. The Commission’s notice instituting the investigation expressly said that opening an investigation was not a decision on the merits. The February 2022 institution notice describes the investigation’s scope.
In March 2022, Sharda moved to terminate the ITC proceeding based on a consent-order stipulation. BASF filed a statement of non-opposition, and the administrative law judge granted the motion. On April 12, the Commission decided not to review that determination, issued consent orders, and terminated the investigation. The Commission’s April 2022 notice records that procedural outcome.
This was a negotiated procedural resolution, not an adjudicated finding that Sharda infringed the patent. The available notices establish that the Commission issued consent orders, but do not provide the full order text or establish its present operative scope. Successful Farming reported in April 2022 that Sharda was required to stop importing and selling products it described as infringing BASF intellectual property. That description should not be expanded into a claim that every product containing pyraclostrobin was covered.
Free tools Windows power users keep installed
One-click scans. No signup required.
#1 Best Overall
Why “judge orders” can be misleading
The headline shorthand refers to an administrative law judge’s action in the ITC case. It does not mean that a federal district-court judge ruled after hearing the patent dispute at trial. The ALJ granted Sharda’s motion to terminate the investigation after the parties’ consent-order stipulation; the Commission then chose not to review that determination and issued consent orders.
BASF also filed a separate patent case in the U.S. District Court for the District of Delaware. The existence of that case does not turn the ITC resolution into a district-court judgment, and the available docket snapshot is too early to establish how the federal case ultimately ended.
ITC investigation and Delaware case were separate proceedings
| Proceeding | Forum and case number | What the available record establishes |
|---|---|---|
| ITC investigation | U.S. International Trade Commission, No. 337-TA-1303 | Concerned imported products containing crystalline modification IV of pyraclostrobin and components thereof. It was terminated in April 2022 after a consent-order stipulation; the Commission issued consent orders. |
| Federal patent case | U.S. District Court for the District of Delaware, No. 1:2022cv00120 | BASF filed a complaint on January 28, 2022. The available docket mirror snapshot was last retrieved March 24, 2022, so it does not establish the case’s later disposition. |
The distinction matters: the ITC proceeding addressed an import-related trade investigation and ended through consent orders. The Delaware case was a separate federal patent lawsuit. The available Delaware docket mirror supports the case identity and early filings, but not a claim about the final result.
What BASF alleged and which patent was identified
BASF said it filed complaints against Sharda Cropchem Ltd. and Sharda USA LLC in both the ITC and the Delaware federal court, alleging infringement of intellectual property concerning pyraclostrobin. The ITC institution notice identified U.S. Patent No. 7,816,392 and claims 1–17, with the investigation focused on imported products containing crystalline modification IV of pyraclostrobin. These are allegations and the stated scope of an investigation—not a neutral finding of infringement.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
BASF’s January 2022 announcement described its complaints and the company’s position. BASF’s statements are useful evidence of what the company asserted, not independent proof of the allegations.
What pyraclostrobin is and BASF products named
Pyraclostrobin is an active ingredient used in fungicides. BASF’s materials named Veltyma, Revytek, Headline SC, Headline, Headline AMP, Priaxor, Pristine, Merivon, Twinline, Nexicor, Cabrio, Insignia, Lexicon, Navicon, and Honor. The company also named the fungicide seed treatments Stamina F3, Stamina F4, and Teraxxa F4.
Rank #4
- Backpack mosquito fogger: 868 Invatech Italia is a powerful mist blower / duster for crop protection & pest control
- Powerful: Invatech fogger features a powerful 51.7cc engine with a tunnel volume of 805 CFM
- Ultra-light: The unit weighs in at an ultra-light 22 pounds, equipped with padded shoulder straps
- Multi-purpose: This mosquito fogger can be filled with both solutions and insecticides
- Mist Output: Invatech Italia sprayer can produce mist output which reaches 39 feet horizontal & 32 feet vertical
Those product names provide agricultural context; they are not a list of products the consent orders necessarily covered. Product formulation and label matter, and the available order text does not establish that every BASF formulation containing pyraclostrobin fell within the orders’ scope.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Timeline of the dispute
- January 28, 2022: BASF filed its Delaware complaint; the ITC notice also identifies this as the complaint date underlying its investigation.
- February 24, 2022: The ITC announced investigation 337-TA-1303 and clarified that instituting the investigation was not a decision on the merits.
- March 4, 2022: Sharda moved to terminate the ITC investigation based on a consent-order stipulation.
- March 14, 2022: BASF filed a statement of non-opposition.
- March 16, 2022: The administrative law judge granted the motion to terminate.
- April 12, 2022: The Commission did not review the ALJ’s determination, issued consent orders, and terminated the investigation.
- April 13, 2022: Successful Farming reported on the resolution.
BASF’s comments and investment claim
Paul Rea, then senior vice president of BASF Agricultural Solutions North America, said: “Farmers rely on innovation from partners like BASF to help improve the yield and quality of their crop,” and welcomed the ALJ’s action. These were statements from a BASF executive, not findings by the ITC or the federal court. Successful Farming’s April 2022 report attributes the remarks to Rea.
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchBest Value
BASF also said that developing each new active ingredient represents an investment of more than $250 million and 10 years. That is BASF’s general estimate about new active ingredients—not an independently verified calculation specific to pyraclostrobin.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
